https://www.fiercepharma.com/pharma/pfi ... -successor
Kathrin Jansen, the leader of Pfizer's vaccine R&D group, has decided to retire, the company's Chief Scientific Officer Mikael Dolsten said in a LinkedIn post. The company plans to conduct a search for her replacement and will name a successor afterward, he said.
Jansen had a long and successful career even before the company's recent breakthrough with its COVID-19 vaccine, Dolsten noted. She was a senior vice president at Wyeth and a member of its R&D executive team before that drugmaker's sale to Pfizer in 2009.
In addition, she previously spent 12 years at Merck Research Laboratories, where she led early research that resulted in the company's groundbreaking HPV vaccine franchise Gardasil.
But it was Jansen's most recent accomplishment on Comirnaty that turned Pfizer into a household name. In partnership with BioNTech, Pfizer's vaccine division—under Jansen's leadership—scored the first COVID-19 vaccine emergency use authorization from the FDA, in December 2020, less than a year into the pandemic.
The Retirement's keep coming...................
- harddriver
- Grand Poobah
- Posts: 5310
- Joined: Mon Jul 05, 2021 5:03 pm
- Has thanked: 588 times
- Been thanked: 1761 times
Who is online
Users browsing this forum: No registered users and 3 guests